Form 8-K Shattuck Labs, Inc. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- S&P Global explores potential separation of Capital IQ business
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
H.C. Wainwright Downgrades Shattuck Labs (STTK) to Neutral
October 1, 2024 10:32 AM EDTH.C. Wainwright analyst Joseph Pantginis downgraded Shattuck Labs (NASDAQ: STTK) from Buy to Neutral.
The analyst comments "Despite encouraging early clinical data; shifting gears away from CD47. This morning, Shattuck announced that following a strategic review of its pipeline and its amassed CD47 data to date in... More
H.C. Wainwright Downgrades Shattuck Labs (STTK) to Neutral
October 1, 2024 10:32 AM EDTH.C. Wainwright analyst Joseph Pantginis downgraded Shattuck Labs (NASDAQ: STTK) from Buy to Neutral.
The analyst comments "Despite encouraging early clinical data; shifting gears away from CD47. This morning, Shattuck announced that following a strategic review of its pipeline and its amassed CD47 data to date in... More



